MedPath

Comparison of metformin and livergol in patients with non-alcoholic fatty liver disease

Phase 3
Conditions
on-alcoholic fatty liver.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20210514051287N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Age over 18 years
Non-alcoholic fatty liver based on ultrasound
increase liver enzymes above normal

Exclusion Criteria

People with suspected fatty liver disease according to history in terms of alcohol consumption, the presence of other concomitant diseases such as hepatitis B, C, insulin use
Pregnancy
Taking effective LFT drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath